The DOI matches its Crossref record; 51 of the 56 references it cites were found in a registry or an index.
Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy
Abstract
Exosomes hold great potential in therapeutic development. However, native exosomes usually induce insufficient effects in vivo and simply act as drug delivery vehicles. Herein, we synthesize responsive exosome nano-bioconjugates for cancer therapy. Azide-modified exosomes derived from M1 macrophages are conjugated with dibenzocyclooctyne-modified antibodies of CD47 and SIRPα (aCD47 and aSIRPα) through pH-sensitive linkers. After systemic administration, the nano-bioconjugates can actively target tumors through the specific recognition between aCD47 and CD47 on the tumor cell surface. In the acidic tumor microenvironment, the benzoic-imine bonds of the nano-bioconjugates are cleaved to release aSIRPα and aCD47 that can, respectively, block SIRPα on macrophages and CD47, leading to abolished "don't eat me" signaling and improved phagocytosis of macrophages. Meanwhile, the native M1 exosomes effectively reprogram the macrophages from pro-tumoral M2 to anti-tumoral M1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meanwhile, native M1 exosomes efficiently reprogram macrophages from pro-tumor M2 to anti-tumor M1 [44].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [44]
In the citing paper
“Their result showed that the nano-bioconjugates could specifically bind with cancer by recognition of CD47.”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [44]
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,954
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
The NF- B Family of Transcription Factors and Its RegulationPreprint
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,944
Crosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,561
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yáng, Z., Tang, W., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712027 · Cited by 1,474
Self-citation
Flagged first, then by citations
5 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Chen F., 1998, Ann. Clin. Lab. Sci., 28, 1
Cited by
Sorted by citations
Items 301–376 of 376
Li, Y., Wang, Z., Gao, Y., Li, Z., Li, J., Zhang, C., He, M., Wang, H., Shi, X., & Shen, M. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202526444 · Cited by 4
Self-citationAdvances of M1 macrophages-derived extracellular vesicles in tumor therapy
Liu, H., Ouyang, Z., & Li, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117735 · Cited by 6
A game of hide-and-seek: how extracellular vesicles evade the immune system
Ghoshal, B., & Jhunjhunwala, S. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01789-w · Cited by 4
Extracellular Vesicle‐Based Antitumor Nanomedicines
Li, M., Liu, Y., Liu, F., Chen, Q., Xu, L., Cheng, Z., Tan, Y., & Liu, Z. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403903 · Cited by 5
Self-citationZhang, W., Yang, T., Jin, T., Zhu, T., Fang, H., Fan, M., & Zhang, Y. (2025) · Advanced Science · doi:10.1002/advs.202506409 · Cited by 4
Self-citationAditi, Khajuria, A., Garima, Kaur, G., Singh, S. K., Dhanawat, M., & Mittal, N. (2025) · Medical Oncology · doi:10.1007/s12032-025-03145-x · Cited by 4
Mitochondria-targeted nanocarriers for smart response delivery of natural products: a review
Cao, J., Lu, W., Lv, Y. L., Li, M., Tang, Y. H., & Feng, Y. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2025.2611940 · Cited by 4
Leveraging macrophage plasticity for precision-targeted tumor immunotherapy
Li, S., Wang, X., Li, L., Chen, L., & Sun, Z.-J. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168176 · Cited by 5
Exosomes in renal cell carcinoma: challenges and opportunities
Mohammadi, M., Mansouri, K., Mohammadi, P., Pournazari, M., & Najafi, H. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09384-x · Cited by 4
Mild Magnetothermal Immunotherapy for Malignant Pleural Effusion
Min, T., Yang, C., Zhang, M., Hu, P., & Shi, J. (2024) · Small · doi:10.1002/smll.202407734 · Cited by 4
Liu, L., Cai, Y., Liu, D., Fang, R., Huang, H., Zou, M., Chen, B., Peng, J., & Hao, L. (2026) · Biomaterials Science · doi:10.1039/d5bm01061f · Cited by 4
Advanced extracellular vesicle immunotherapy
Zhang, J., Mu, Y., Ji, X., Jiang, X., Wang, R., Ding, X., & Wang, L. (2026) · FlexMat. · doi:10.1002/flm2.70030 · Cited by 4
Self-citationSun, Z., Zhou, R., Liu, J., Zhao, Q., Sun, C., & Sun, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154506 · Cited by 3
Zhao, H., Du, F., Guo, R., & Qiu, L. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01154j · Cited by 3
Li, X., Zeng, X., & Hu, X. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130419 · Cited by 3
Nano‐Engineering Strategies for Tumor‐Specific Therapy
Li, Z., Xie, H., & Nie, W. (2024) · ChemMedChem · doi:10.1002/cmdc.202300647 · Cited by 3
Self-citationWITHDRAWN: Engineering Exosomes and Exosome-like Nanovesicles for Improving Targeted Retention
Li, L., Wang, F., Zhu, D., Hu, S., Cheng, K., & Li, Z. (2024) · Fundamental Research · doi:10.1016/j.fmre.2023.11.024 · Cited by 3
RetractedEngineered macrophages as versatile platforms for targeted cancer immunotherapy
Mujahid, K., Aslam, M. A., Nam, J., & Choi, J. U. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00754-6 · Cited by 2
Recombinant PD1 liposome loading nintedanib for pulmonary fibrosis therapy in mice
Luo, Q., Xie, Y., Xu, J., Ren, Y., Xiong, S., Zhang, H., Chen, Y., Chen, H., Wang, J., Huang, P., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169905 · Cited by 2
Self-citationLiu, X., Hu, Y., Zhang, Y., Liu, C. X., Wu, J., Zhao, R., Xue, Z., Zhou, W., Liu, X., Miletić, H., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102680 · Cited by 2
Self-citationZhao, X., Feng, Y., Ke, Y., & Yang, W. (2026) · New Journal of Chemistry · doi:10.1039/d5nj04505c · Cited by 2
Extracellular Vesicles in Ophthalmology: From Natural Nanocarriers to Engineered Therapeutics
Flores, C., Mastantuono, F., Huang, L. J., McKay, T. B., Coyne, G., Hefley, B. S., Vasini, B., Karamichos, D., & Yang, M. (2026) · Bioengineering · doi:10.3390/bioengineering13030275 · Cited by 3
Self-citationEngineered Extracellular Vesicles: Advancing Cancer Therapy Through Precision Nanomedicine
Ma, S., Niu, Y., Sui, S., Xu, W., Kong, L., Wu, X., Wu, J., Gao, Y., & Yan, T. (2026) · BIO Integration · doi:10.15212/bioi-2025-0208 · Cited by 2
Feng, S., Zhang, Y. X., Gao, Y., Liu, Y., Wang, Y., Han, X., Zhang, T., & Song, Y. (2023) · Angewandte Chemie · doi:10.1002/ange.202313968 · Cited by 2
Self-citationLi, W., Yu, Z., Wu, Z., Jia, J., & Chen, G. (2024) · Translational dental research. · doi:10.1016/j.tdr.2024.100004 · Cited by 2
Dhara, A., Majumder, S., Pahari, S., & Kar, D. (2023) · BioNanoScience · doi:10.1007/s12668-023-01065-6 · Cited by 2
Sun, T., Li, C., Li, X., Song, H., Su, B., You, H., Zhang, T., & Jiang, C. (2022) · Micro/Nano technologies · doi:10.1007/978-981-13-9374-7_10-1 · Cited by 1
Why Extracellular Vesicles Are Attractive Vehicles for RNA-Based Therapies?
Aqel, F., Schneider, K., Hartung, D., Schwarz, K., & Shatnyeva, O. (2024) · SynBio · doi:10.3390/synbio2040024 · Cited by 1
Yang, Z., Zhang, W., Wei, L. G., qu, Y., Jiazi, Y., & Liu, Q. (2025) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/a-2599-4212 · Cited by 1
Lee, P., Liao, M.-H., Birhan, Y. S., Syu, W.-J., Li, C.-Z., Peng, C., Hu, C.-C., & Lai, P. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.09.046 · Cited by 1
Zhang, J., Zhang, Y., Wu, H., Shi, S., Cao, S., Chen, H., & Song, Y. (2025) · Archives of Virology · doi:10.1007/s00705-025-06459-3 · Cited by 1
Self-citationNanomedicine-driven strategies for CD8+ T cell enhancement in Cancer immunotherapy
Gao, Z., Chen, C., Chen, X., Yao, P., Li, W., Fan, Y., Wang, S., Sun, M., Sun, K., & Zhang, J. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217468 · Cited by 1
Self-citationControlled Assembly of Vesicle-Based Superstructures Using Megamolecules
Vu, T. Q., Sridhar, S., Shekour, B. G., Iyer, A., Cline, L., Kimmel, B. R., Modica, J. A., Mocan, L., Mrksich, M., & Kamat, N. P. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c23536 · Cited by 1
Tong, C., Zhang, J., Yajing, Z., Yu, X., Zang, S., & Liu, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-40683-4 · Cited by 1
Self-citationExtracellular Vesicles‐Functionalized Biomaterials for Oral Disease Theragnostics
Zhao, Z., Zeng, Y., Liu, R., & Qiu, X. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70048 · Cited by 1
Shi, H., Chen, Y., Huang, Z., Shen, C., Xiao, J., Zhao, H., Zou, Z., Zhang, W., Feng, K., Ou, Z., et al. (2026) · Microstructures · doi:10.20517/microstructures.2025.132 · Cited by 1
Hu, Y., Yang, X., Shu, F., Jin, L., Sarsaiya, S., Han, S., & Chen, J. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126846 · Cited by 2
The Role of Extracellular Vesicles in Tumor Therapy and Imaging
Feng, T., Wan, Y., Cui, S., & Liu, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300195 · Cited by 1
Self-citationNew Progress in the Treatment of Refractory Epilepsy
景, 世. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122627 · Cited by 1
Xu, X., Li, S., Yu, W., Yao, S., Fan, H., & Guo, Z. (2024) · Angewandte Chemie · doi:10.1002/ange.202318544 · Cited by 1
Exosomes: Key Players for Treatment of Cancer and Their Future Perspectives
Gupta, R., Gupta, J., & Roy, S. (2024) · Assay and Drug Development Technologies · doi:10.1089/adt.2023.026 · Cited by 1
Exosomes as novel nanocarriers for cancer therapy
Li, J., Zan, J., Xu, Z., Yang, C., Han, X., Huang, S., Xu, H., & Zhen, Y. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106262 · Cited by 2
Self-citationCell-derived nanoplatforms for cancer therapy
Lins, P. M. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2021.tde-03092021-114705 · Cited by 1
NIR Light‐Activated Conversion Nanomaterials for Photothermal/Immunotherapy
Zhang, Y., & Hou, Z. (2025) · Wiley eBooks · doi:10.1002/9783527845347.ch12 · Cited by 1
Self-citationQian, H., Fu, Y., Guo, M., Wu, Y. F., Zhang, D., Zhou, T., Fang, W., Yao, M., Shi, H., Chai, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-373672/v1
Engineered extracellular vesicles as drug delivery systems for the next generation of nanomedicine
Fan, Z., & Jiang, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00010-0
Recent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment
Zhang, H. (2023) · MDPI eBooks · doi:10.3390/books978-3-0365-7040-2
The Effect of Engineering Methods on the Efficacy of Therapeutic Exosomes
Zhang, C. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v65i.11230
Biomedical Applications of Extracellular Vesicles in Treatment of Disease
Wang, F., Ai, J., Zhang, Z., Li, Y., & Li, Z. (2023) · Wiley eBooks · doi:10.1002/9783527842155.ch4
Technologies for the Surface Functionalization of Extracellular Vesicles
Han, G., Geng, M., & Yin, H. (2024) · Springer eBooks · doi:10.1007/978-981-99-8365-0_11
Zhu, J., Zhuang, L., & Yang, Y. (2025) · Noordanesh. · doi:10.61186/ijkd.9123
Rapid Detection of Plasma Exosomal Casc9 for Hcc Using Rt-Rpa-Crispr/Cas12a AssayPreprint
Wu, J., Li, X., Yin, X., Hu, J., Zhou, P., Zhong, X., & Wu, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5226218
Karmakar, S., Tadge, T. S., Devidas, S. G., & Raichur, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29125-8.00012-0
Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications
Hussain, Z., Ahmed, W., Gao, T., Zhang, Y., & Pei, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_2
Self-citationBiological Membrane Engineering for Unlocking Therapeutic Potential of Membrane-Based Platforms
Ahmed, W., Hussain, Z., & Pei, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_1
Sun, H., Chu, Z., & Liang, Q. (2025) · Small · doi:10.1002/smll.202509696
Meng, M., Zhang, X., Li, Q., Han, J., Chen, Y., Qiao, H., Yang, Y., & Huang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26573194
Li, Q., Lin, Q., Du, H., & Ou, Z. (2026) · Obstetrics and gynecology. · doi:10.5772/intechopen.1014084
Co-Extracellular Vesicles Delivery System Enhances Immunochemotherapy for Glioblastoma
Niu, W., Guan, R., Sun, L., Wang, M., Wang, X., Zhang, B., Hao, X., Wu, Q., Cheng, Z., Wei, J., et al. (2026) · Research · doi:10.34133/research.1219
Self-citationThe multifaceted mechanisms of Tanshinone IIA in doxorubicin-induced cardiotoxicity
Wang, Q., Zou, D., Chen, H., Cui, D., Huang, X., Chen, Y., Qi, Y., Nan, Z., Wang, X., & Shang, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1783433
Therapeutic Applications of Stimuli‐Based Release and Engineering of Extracellular Vesicles
Kemunto, G., & Dellinger, K. (2026) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500173
Functionalization of extracellular vesicles for biomedical applications
Rani, S., Hussain, Z., & Pei, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00009-7
Banjare, N., Singh, M., Kuiry, A., & Gupta, P. N. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115798
Zhang, J., Tong, T., Cai, C., Cai, X., Sun, B., Wen, K., Qu, X., Fan, Q., & Dong, Z. (2026) · ACS Nano · doi:10.1021/acsnano.6c06363
Self-citationThe CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation
Li, H., Lei, X., & Yang, X. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109069
Extracellular vesicles in solid tumors: from tumor ecology to engineered therapeutics
Cai, W., Chen, Y., Dai, S., Cheng, C., & Chen, L. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02705-7
Engineered Exosomes for Skin Antiaging: A New Frontier in Regenerative Medicine
Sun, Y. W., Guo, X., He, Z., Cui, Y., Wen, D., Xue, B., & Li, L. (2026) · The FASEB Journal · doi:10.1096/fj.202601698r
Ma, Y.-J., Zhang, Z., Kang, J., Che, X.-H., Tian, J.-Y., Cai, Y.-Y., Shen, S., Zhao, D., & Zhu, L. (2026) · Biomaterials Science · doi:10.1039/d6bm00886k
Zhao, X., Hu, Z., Xu, Q., Zou, J., Huo, J., Yang, Y., Yang, J., & Zhang, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179697
Recent advances in stimulus-responsive nanomaterials for the treatment of inflammatory bowel disease
Zhang, Y., Zhao, Y., Xu, P., Zhang, C. L., Chen, X., Guo, J., He, B., & Liang, Y. (2026) · Nanoscale · doi:10.1039/d6nr01522k
Self-citationJahromi, L. P., Geng, F., Frenzke, J., & Fuhrmann, G. (2026) · Advanced Materials · doi:10.1002/adma.74203
Programmable nanomedicine via bioorthogonal molecular engineering
Im, S., Koo, S., & Kim, J. S. (2026) · Nano Convergence · doi:10.1186/s40580-026-00568-8 · Cited by 1
Zhang, X., Zhou, X., Fu, S., Liu, X., Xie, Y., Zhang, Y., Fang, Y., & Yu, J. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101215
Self-citationEngineered exosomes for breast cancer immunotherapy: Emerging strategies and translational potential
Orooji, N., Ghasemian-Irani, M., Salari, N., Eskandari, T., Shams, M., Razavi, F. T., & Haghmorad, D. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102822
Ban, M., Zhao, S., Liu, Z., & Zhao, L. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101273
Liu, X., Zhou, J., Lu, G., Zhao, C., Wang, W., Chen, J., Zhang, F., Zhang, F., Xie, H.-Y., & Nie, W. (2026) · Advanced Science · doi:10.1002/advs.78279
Self-citation
Metadata
- Authors
- Nie, W., Wu, G., Zhang, J., Huang, L., Ding, J., Jiang, A., Zhang, Y., Liu, Y., Li, J., Pu, K., & Xie, H.
- Affiliations
- Beijing Institute of Technology (CN)
- Chinese Academy of Sciences (CN)
- School of Chemical and Biomedical Engineering Nanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
- Nanyang Technological University (SG)
- School of Life Science Beijing Institute of Technology Beijing 100081 P. R. China
- Corresponding author
- Pu, Kanyi
- ORCID
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2019-12-18
- Volume
- 59
- Issue
- 5
- Pages
- 2018-2022
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2991079475
- Cited by
- 376
- References
- 56
- Citations by year
- 2026: 39 · 2025: 52 · 2024: 69 · 2023: 71 · 2022: 65 · 2021: 52 · 2020: 28
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- exosomes, cancer therapy, CD47, SIRPα, M1 macrophages, macrophage reprogramming, tumor microenvironment, tumor targeting, phagocytosis, macrophage polarization
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Nanotechnology, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review